Compare Cassava Sciences Inc (FLNA) vs iShares 7-10 Year Treasury Bond ETF (IEF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs iShares 7-10 Year Treasury Bond ETF — how do they compare? Cassava Sciences Inc trades at $0.94 (market cap $47.75M), while iShares 7-10 Year Treasury Bond ETF trades at $93. Which is the better fit depends on your goals.
| FLNA | IEF | |
|---|---|---|
Market Cap | $47.75M | — |
Sector | Health | — |
52-Week High | $4.64 | $97.99 |
52-Week Low | $0.87 | $92.76 |
Enterprise Value | -$34.93M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.9528, down 4.46% today, with a bearish technical outlook but strong analyst support (66.7% buy ratings). The company continues to post net losses and negative cash flows, though recent EPS beats show some operational improvement. Recent news highlights Q2 2026 results and business updates on Tuberous Sclerosis Complex therapies.
The outlook remains speculative due to persistent unprofitability and cash burn, but analyst optimism and a low P/B ratio of 0.75 may attract value investors. Key risks include execution challenges in drug development and reliance on financing amid negative earnings.
IEF trades at $93.075 with a modest 0.34% daily gain, though technical indicators show a bearish trend with moving averages signaling sell pressure. The ETF maintains consistent dividend distributions, with recent payouts of $0.31-$0.32 per share. Market sentiment is influenced by Treasury yield fluctuations and institutional positioning, with Bank of America increasing its stake by 69.8% in Q2 2026.
The outlook remains cautious as rising Treasury yields and inflation concerns pressure bond ETFs. Institutional accumulation provides support, but technical weakness and macroeconomic headwinds suggest limited near-term upside. Key risks include Fed rate policy uncertainty and oil price volatility affecting inflation expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About iShares 7-10 Year Treasury Bond ETF
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →
